YCM
CTKB icon

Yousif Capital Management’s Cytek Biosciences CTKB Stock Holding History

Yousif Capital Management’s Portfolio CTKB Stock Details CTKB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-27,078
Closed -$118K – 1692
2026
Q1 		$118K Buy
27,078
+468
+2% +$2.21K ﹤0.01% 1824
2025
Q4 		$141K Sell
26,610
-971
-4% -$4.51K ﹤0.01% 1831
2025
Q3 		$95.7K Sell
27,581
-3,621
-12% -$13.6K ﹤0.01% 1867
2025
Q2 		$106K Hold
31,202
– – ﹤0.01% 1891
2025
Q1 		$125K Sell
31,202
-751
-2% -$3.89K ﹤0.01% 1866
2024
Q4 		$207K Buy
31,953
+415
+1% +$2.47K ﹤0.01% 1814
2024
Q3 		$175K Sell
31,538
-2,743
-8% -$15.6K ﹤0.01% 1877
2024
Q2 		$191K Sell
34,281
-11,165
-25% -$67.1K ﹤0.01% 1846
2024
Q1 		$305K Sell
45,446
-4,245
-9% -$33.6K ﹤0.01% 1730
2023
Q4 		$453K Buy
49,691
+240
+0.5% +$1.51K 0.01% 1579
2023
Q3 		$273K Buy
49,451
+5,990
+14% +$48K ﹤0.01% 1744
2023
Q2 		$371K Buy
+43,461
New +$390K ﹤0.01% 1633

Other funds holding CTKB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
CFM
Catalyst Funds Management Sydney NSW, Australia $1.78B AUM 107.3% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Yousif Capital Management's CTKB Position: Q2 2026 in Review

Yousif Capital Management sold out of Cytek Biosciences (CTKB) in Q2 2026, closing a stake of 27,078 shares — an estimated $118K sold.

Yousif Capital Management first reported a position in CTKB in Q2 2023 and held it in 12 quarters. The position peaked at $453K in Q4 2023. 49 funds tracked by Wall St. Rank hold CTKB as of Q2 2026.

  • Yousif Capital Management reported no remaining Cytek Biosciences position as of Q2 2026 after selling out during the quarter.
  • Yousif Capital Management sold 27,078 Cytek Biosciences shares in Q2 2026, an estimated $118K.
  • Yousif Capital Management first reported a position in Cytek Biosciences in Q2 2023 and held it in 12 quarters.
  • Yousif Capital Management's Cytek Biosciences position peaked at $453K in Q4 2023.
  • 49 funds tracked by Wall St. Rank held Cytek Biosciences as of Q2 2026.

Based on Yousif Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.